{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:58:16Z","timestamp":1785855496125,"version":"3.56.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1097\/01.mbc.0000172099.04040.93","type":"journal-article","created":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T12:44:35Z","timestamp":1119357875000},"page":"337-340","source":"Crossref","is-referenced-by-count":4,"title":["The influence of acetylsalicylic acid intake by healthy volunteers on duplicate PFA-100 measurements"],"prefix":"10.1097","volume":"16","author":[{"given":"Jacqueline MT","family":"Klein Gunnewiek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid HI","family":"Hovestad-Witterland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst J","family":"Vollaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke WHA","family":"Fleuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno de","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.CIR.72.6.1177","article-title":"Clinical pharmacology of platelet cyclooxygenase inhibition","volume":"72","author":"Patrono","year":"1985","journal-title":"Circulation"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1096\/fasebj.5.9.1907252","article-title":"Human platelet\/erythroleukemia cell prostaglandin G\/H synthase: cDNA cloning, expression, and gene chromosomal assignment","volume":"5","author":"Funk","year":"1991","journal-title":"FASEB J"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"11B","DOI":"10.1016\/0002-9149(91)90379-Y","article-title":"Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists","volume":"68","author":"FitzGerald","year":"1991","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.119.1_suppl.39S","article-title":"Platelet-active drugs: the relationship among dose, effectiveness, and side-effects","volume":"119","author":"Patrono","year":"2001","journal-title":"Chest"},{"key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"suppl 2","key":"R6-5-20210203","first-page":"106","article-title":"Description of an in vitro platelet function analyzer PFA 100\u2122","volume":"21","author":"Kundu","year":"1995","journal-title":"Semin Thromb Hemostas"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2125.1997.00639.x","article-title":"A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers","volume":"44","author":"Marshall","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100\u00ae","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb Haemost"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent cerebral ischemic attacks","volume":"250","author":"Grundmann","year":"2003","journal-title":"J Neurol"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-0038-1660415","article-title":"Determination and treatment of disorders of primary haemostasis \u2014 experience with routine application of the in vitro bleeding test","volume":"19","author":"Kretschmer","year":"1999","journal-title":"Haemostaseologie"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0049-3848(97)00115-1","article-title":"Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100\u2122 system","volume":"87","author":"Heilmann","year":"1997","journal-title":"Thromb Res"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/ac00284a003","article-title":"Enzyme immunoassays of eicosanoids using acetylcholinesterase as label: an alternative to radioimmunoassay","volume":"57","author":"Pradelles","year":"1985","journal-title":"Anal Chem"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1365-2125.2002.01605.x","article-title":"A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers","volume":"53","author":"van Kraaij","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R14-5-20210203","first-page":"443","article-title":"Evaluation of a platelet function analyzer (PFA-100\u00ae) in patients with a bleeding tendency","volume":"132","author":"Wuillemin","year":"2002","journal-title":"Swiss Med Weekly"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0049-3848(99)00236-4","article-title":"Platelet function analysis with PFA-100\u00ae in patients medicated with acetylsalicylic acid strongly depends on concentration of sodium citrate used for anticoagulation of blood sample","volume":"98","author":"von Pape","year":"2000","journal-title":"Thromb Res"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0049-3848(02)00405-X","article-title":"Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease","volume":"108","author":"Andersen","year":"2002","journal-title":"Thromb Res"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.STR.0000106763.46123.F6","article-title":"Antiplatelet effect of aspirin in patients with cerebrovascular disease","volume":"35","author":"Alberts","year":"2004","journal-title":"Stroke"},{"key":"R19-5-20210203","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.STR.25.12.2331","article-title":"Development of aspirin resistance in persons with previous ischemic stroke","volume":"25","author":"Helgason","year":"1994","journal-title":"Stroke"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mbc.0000172099.04040.93","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:39:58Z","timestamp":1785854398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200507000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000172099.04040.93","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}